Foam is
the future
ExEm® Foam ((air polymer-type A) intrauterine foam) is an innovative, FDA-approved contrast drug that allows for ultrasound tubal patency testing in women with known or suspected infertility.
The foam offers a less complicated, less invasive alternative to the gold standard for diagnosing tubal patency – laparoscopy.1
The Science
Proven accuracy. Minimum invasiveness.
Studies suggest that, with proper imaging technique, hysterosalpingo-foam sonography (HyFoSy) with ExEm® Foam does not significantly differ from laparoscopy with dye and has the ability to achieve significantly higher accuracy than hysterosalpingo-contrast sonography with air/saline, making it an attractive new alternative for tubal patency assessment and diagnosis in women with known or suspected infertility.1,2

HOW IT WORKS
More knowledge.
More empowerment.
How ExEm® Foam works is simple: if the fallopian tubes are patent — or open — the foam will appear as a thin, bright white line, when visualized with ultrasound by your healthcare provider. If the white line does not appear, the tubes might be occluded — or blocked.
After the procedure, the results can immediately be discussed with your physician in more detail and used to help plan the next steps in your fertility journey.

Explore the benefits of ExEm® Foam
The fertility journey doesn’t have to be more complicated than needed. ExEm® Foam provides a new solution for healthcare professionals to offer a more patient-friendly tubal patency assessment for women with known or suspected infertility.
Explore the benefits for patients and healthcare professionals.